Pregnancy Outcome and Safety of Interrupting Therapy for Women With Endocrine Responsive Breast Cancer |
Endocrine therapy interruption |
Active, not recruiting |
Prophylactic Antiviral Therapy in Patients With Current or Past Hepatitis B Virus Infection Receiving Anti-Cancer Therapy for Solid Tumors |
Entecavir, Tenofovir Disoproxil Fumarate, Best Practice, Tenofovir Alafenamide |
Active, not recruiting |
Radiation Therapy With or Without Trastuzumab in Treating Women With Ductal Carcinoma In Situ Who Have Undergone Lumpectomy |
Trastuzumab, Whole Breast Irradiation, Laboratory Biomarker Analysis |
Active, not recruiting |
Reaching Rural Cancer Survivors Who Smoke Using Text-Based Program |
Health Promotion and Education, Informational Intervention, Questionnaire Administration, Smoking Cessation Intervention |
Recruiting |
Relaxation for Women with Breast Cancer Undergoing Radiotherapy |
Questionnaires, Relaxation Program, Saliva Testing |
Active, not recruiting |
Reproductive Health Program in Patients With Cancer |
Standard practice related to reproductive heath, Training modules, algorithm, referral development |
Active, not recruiting |
S0820, Adenoma and Second Primary Prevention Trial |
Eflornithine placebo & sulindac, Eflornithine placebo & sulindac placebo, Eflornithine plus sulindac, eflornithine & sulindac placebo |
Active, not recruiting |
S1501 Carvedilol in Preventing Cardiac Toxicity in Patients With Metastatic HER-2-Positive Breast Cancer |
Carvedilol, Laboratory Biomarker Analysis, Patient Observation |
Recruiting |
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer |
Anxiety Questionnaire Administration, Quality-of-Life Assessment, Serum Tumor Marker directed disease monitoring, Usual care disease monitoring |
Recruiting |
Simplified Patient Care Strategy in Decreasing Early Death in Patients With Acute Promyelocytic Leukemia |
Best Practice, Laboratory Biomarker Analysis, Supportive Care |
Active, not recruiting |